Russell Frank Company’s Medicines Co MDCO Stock Holding History

Russell Frank Company’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$298K	Sell	9,392 -11	-0.1%	-$359	﹤0.01%	2608
2015 Q4	$352K	Sell	9,403 -13,426	-59%	-$507K	﹤0.01%	2576
2015 Q3	$867K	Buy	+22,829	New	+$801K	﹤0.01%	2257
2015 Q2	–	Sell	-1,787	Closed	-$50K	–	3118
2015 Q1	$50K	Buy	1,787 +787	+79%	+$22.1K	﹤0.01%	2809
2014 Q4	$28K	Buy	1,000 +820	+456%	+$20.3K	﹤0.01%	2853
2014 Q3	$4K	Buy	+180	New	+$4.57K	﹤0.01%	2834
2014 Q2	–	Sell	-8,563	Closed	-$218K	–	2896
2014 Q1	$218K	Hold	8,563	–	–	﹤0.01%	2556
2013 Q4	$300K	Sell	8,563 -4,862	-36%	-$174K	﹤0.01%	2488
2013 Q3	$450K	Sell	13,425 -54	-0.4%	-$1.72K	﹤0.01%	2527
2013 Q2	$415K	Buy	+13,479	New	+$451K	﹤0.01%	2385

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Frank Company's MDCO Position: Q1 2016 in Review

Russell Frank Company reduced its Medicines Co (MDCO) stake by 0.12% in Q1 2016, selling an estimated $359 and leaving 9,392 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Russell Frank Company first reported a position in MDCO in Q2 2013 and has held it in 10 quarters since. The position peaked at $867K in Q3 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

Russell Frank Company held 9,392 shares of Medicines Co worth $298K as of Q1 2016.
Russell Frank Company sold 11 Medicines Co shares in Q1 2016, an estimated $359.
Medicines Co made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2608 holding.
Russell Frank Company first reported a position in Medicines Co in Q2 2013 and has held it in 10 quarters since.
Russell Frank Company's Medicines Co position peaked at $867K in Q3 2015.
181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.